| 1 |
Gemcitabine |
95058-81-4 |
| 2 |
Capecitabine |
154361-50-9 |
| Under development at Lab / Plant Scale |
|
| 1 |
Erlotinib Hydrochloride |
183321-74-6 |
| 2 |
Gefitinib |
184475-35-2 |
| 3 |
Imatinib Mesylate |
220127-57-1 |
| 4 |
Pemetrexed Disodium Hemipentahydrate |
137281-23-3 |
| Under Evaluation or Research |
|
|
| 1 |
Bortezomib |
179324-69-7 |
| 2 |
Bosutinib |
380843-75-4 |
| 3 |
Dasatinib |
302962-49-8 |
| 4 |
Docetaxel |
114977-28-5 |
| 5 |
Doxorubicin |
23214-92-8 |
| 6 |
Epirubicin |
56420-45-2 |
| 7 |
Exemestane |
107868-30-4 |
| 8 |
Ixabepilone |
219989-84-1 |
| 9 |
Lapatinib Ditosylate |
231277-92-2 |
| 10 |
Methotrexate |
59-05-2 |
| 11 |
Nilotinib |
641571-10-0 |
| 12 |
Paclitaxel |
33069-62-4 |
| 13 |
Sorafenib |
284461-73-0 |
| 14 |
Sunitinib |
557795-19-4 |
| 15 |
Temozolomide |
85622-93-1 |
